FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

70961008: Neomycin sulfate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
117867011 Neomycin sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
501730016 Neomycin sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
811074015 Neomycin sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2796001000005112 Neomycinsulfat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neomycin sulfate Is a Product containing neomycin (medicinal product) false Inferred relationship Some
Neomycin sulfate Is a Baktericid false Inferred relationship Some
Neomycin sulfate Is a Neomycin (substance) false Inferred relationship Some
Neomycin sulfate Is a Substance with aminoglycoside structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Neomycin sulfate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Neomycin (substance) true Inferred relationship Some
Neomycin sulfate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Neomycin sulfate Inferred relationship Some 3
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Neomycin sulfate Inferred relationship Some 3
Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Neomycin sulfate Inferred relationship Some 3

Start Page 2 of 2


This concept is not in any reference sets

Back to Start